The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

James Herriott Biography and Net Worth

General Counsel of Exact Sciences

James Herriott has served as our Senior Vice President, General Counsel since January 2022 and our Secretary since December 2022. Mr. Herriott previously served as our Deputy General Counsel from February 2020 until January 2022 and Senior Counsel from August 2018 to February 2022. He joined us from the global law firm K&L Gates LLP, where he practiced corporate and securities law. Prior to his tenure at K&L Gates, Mr. Herriott practiced corporate and securities law at Paul Hastings LLP. Mr. Herriott earned a bachelor’s degree in economics from Duke University and a Juris Doctorate from Vanderbilt University Law School.

What is James Herriott's net worth?: The estimated net worth of James Herriott is at least $519,938.20 as of May 1st, 2024. Mr. Herriott owns 9,866 shares of Exact Sciences stock worth more than $519,938 as of November 21st. This net worth approximation does not reflect any other assets that Mr. Herriott may own. Learn More about James Herriott's net worth.
How old is James Herriott?: Mr. Herriott is currently 44 years old. There are 6 older executives and no younger executives at Exact Sciences. The oldest executive at Exact Sciences is Mr. Kevin T. Conroy, Chairman of The Board & CEO, who is 58 years old. Learn More on James Herriott's age.
How do I contact James Herriott?: The corporate mailing address for Mr. Herriott and other Exact Sciences executives is 5505 ENDEAVOR LANE, MADISON WI, 53719. Exact Sciences can also be reached via phone at (608) 284-5700 and via email at [email protected]. Learn More on James Herriott's contact information.
Has James Herriott been buying or selling shares of Exact Sciences?: James Herriott has not been actively trading shares of Exact Sciences in the last ninety days. Most recently, James Herriott sold 30 shares of the business's stock in a transaction on Wednesday, May 1st. The shares were sold at an average price of $60.15, for a transaction totalling $1,804.50. Following the completion of the sale, the senior vice president now directly owns 9,866 shares of the company's stock, valued at $593,439.90. Learn More on James Herriott's trading history.
Who are Exact Sciences' active insiders?: Exact Sciences' insider roster includes Brian Baranick (Insider), Sarah Condella (SVP), Kevin Conroy (CEO), D. Coward (Insider), Everett Cunningham (Insider), James Doyle (Director), Jeffrey Elliott (CFO), James Herriott (General Counsel), Torsten Hoof (Insider), Daniel Levangie (Director), Graham Lidgard (Insider), Jacob Orville (Insider), and Katherine Zanotti (Director). Learn More on Exact Sciences' active insiders.
Are insiders buying or selling shares of Exact Sciences?: In the last twelve months, Exact Sciences insiders bought shares 1 times. They purchased a total of 19,500 shares worth more than $1,001,325.00. In the last twelve months, insiders at the medical research company sold shares 36 times. They sold a total of 77,348 shares worth more than $4,737,043.93. The most recent insider tranaction occured on November, 13th when CEO Kevin T Conroy bought 19,500 shares worth more than $1,001,325.00. Insiders at Exact Sciences own 1.4% of the company. Learn More about insider trades at Exact Sciences.
Information on this page was last updated on 11/13/2024.

James Herriott Insider Trading History at Exact Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/1/2024	Sell	30	$60.15	$1,804.50	9,866
3/1/2024	Sell	862	$59.32	$51,133.84	9,125
2/27/2024	Sell	784	$56.89	$44,601.76	8,097
2/21/2024	Sell	415	$61.50	$25,522.50	6,943
2/15/2024	Sell	421	$61.43	$25,862.03	6,494
7/19/2023	Sell	1,300	$100.00	$130,000.00	5,964
6/8/2023	Sell	1,300	$90.00	$117,000.00	7,264
5/10/2023	Sell	1,300	$79.85	$103,805.00	8,564
2/28/2023	Sell	2,225	$60.43	$134,456.75	9,224
2/15/2023	Sell	400	$65.59	$26,236.00	9,095

James Herriott Buying and Selling Activity at Exact Sciences

Exact Sciences Company Overview

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Today's Range

Now: $52.70

$51.71

$54.17

50 Day Range

MA: $65.32

$49.33

$71.93

2 Week Range

Now: $52.70

$40.62

$79.62

Volume

2,141,771 shs

Average Volume

2,645,736 shs

Market Capitalization

$9.75 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27

Financial Prophecy

From Porter & Company | Ad